Peptide Labs Market 2026: $5.8B Growth, 12.3% CAGR Driven by GLP-1s & Research Peptide Innovation
Title: Peptide Labs Market 2026: $5.8B Growth, 12.3% CAGR Driven by GLP-1s & Research Peptide Innovation Abstract: The peptide labs market is projected to reach $5.8 billion by 2026, expanding at a 12.3% CAGR, fueled by GLP-1 receptor agonists and research peptide innovation. This analysis evaluates product composition (e.g., GLP-1s, growth hormone secretagogues), comparing brands like Bachem and Novo Nordisk on purity (>98%) and stability. Key technical trade-offs include high bioactivity versus short half-life, requiring lyophilized storage. Market trends highlight a shift toward GMP-certified facilities, with 73% of buyers prioritizing third-party HPLC/MS reports. Logistics demand cold-chain compliance (-20°C) to maintain potency. Selection criteria emphasize COA verification, supplier ISO 9001 accreditation, and batch consistency. Industry outlook remains robust, driven by metabolic disease applications and anti-aging research.